51 Grants (Page 2 of 3)
2010
GENE EXPRESSION CORE
Geraci, Mark W
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5P30CA046934-23), $139,980USD, 2010
 
Lung Genomics Research Consortium
Geraci, Mark W⋅Kaminski, Naftali⋅Quackenbush, John⋅Schwartz, David A⋅Sciurba, Frank and Spira, Avrum E
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 7RC2HL101715-03), $1,654,805USD, 09/30/2009 -- 08/31/2012
 
Lung Genomics Research Consortium
Geraci, Mark W⋅Kaminski, Naftali⋅Quackenbush, John⋅Schwartz, David A⋅Sciurba, Frank and Spira, Avrum E
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5RC2HL101715-02), $3,759,656USD, 09/30/2009 -- 06/30/2011
 
Mechanisms of Prostacyclin signaling in Pulmonary Arterial Hypertension
Geraci, Mark W
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5P01HL014985-37), $307,049USD, 2010
 
Molecular Physiology Core Applied to Acute Lung Injury
Geraci, Mark W
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5P30HL101295-02), $514,028USD, 09/30/2009 -- 08/31/2011
2009
Colorado Career Development Program in the Genetics and Genomics of Lung Diseases
Geraci, Mark W
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5K12HL090147-03), $399,600USD, 09/27/2007 -- 07/31/2012
 
GENE EXPRESSION CORE
Geraci, Mark W
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5P30CA046934-22), $148,080USD, 2009
 
Lung Genomics Research Consortium
Geraci, Mark W⋅Kaminski, Naftali⋅Quackenbush, John⋅Schwartz, David A⋅Sciurba, Frank and Spira, Avrum E
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 1RC2HL101715-01), $5,987,215USD, 09/30/2009 -- 08/31/2011
 
Mechanisms of Prostacyclin signaling in Pulmonary Arterial Hypertension
Geraci, Mark W
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 2P01HL014985-36A1), $225,652USD, 07/01/2009 -- 06/30/2014
 
Molecular Physiology Core Applied to Acute Lung Injury
Geraci, Mark W
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 1P30HL101295-01), $527,802USD, 09/30/2009 -- 08/31/2011
2008
Colorado Career Development Program in the Genetics and Genomics of Lung Diseases
Geraci, Mark W
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5K12HL090147-02), $399,600USD, 09/27/2007 -- 07/31/2012
 
GENE EXPRESSION CORE
Geraci, Mark W
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5P30CA046934-21-9014), $139,247USD, 2008
 
Prostacyclin Synthase and Receptors in Pulmonary Arterial Hypertension
Geraci, Mark W
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 1R01HL089508-01A1), $321,518USD, 09/15/2008 -- 08/31/2012
2007
Colorado Career Development Program in the Genetics and Genomics of Lung Diseases
Geraci, Mark W
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 1K12HL090147-01), $399,600USD, 09/27/2007 -- 07/31/2012
 
GENE EXPRESSION CORE
Geraci, Mark W
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5P30CA046934-20), $135,465USD, 2007
2006
GENE EXPRESSION CORE
Geraci, Mark W
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 2P30CA046934-19), $75,140USD, 02/01/2006 -- 01/31/2011
2005
Expression Analysis to Study Disease Pathogenesis
Geraci, Mark W
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5R01HL072340-04), $767,020USD, 09/30/2002 -- 07/31/2008
 
Molecular Biology Core
Geraci, Mark W
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5P01HL068743-04), $252,187USD, 2005
2004
Expression Analysis to Study Disease Pathogenesis
Geraci, Mark W
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5R01HL072340-03), $766,064USD, 09/30/2002 -- 07/31/2006
2003
Expression Analysis to Study Disease Pathogenesis
Geraci, Mark W
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5R01HL072340-02), $754,770USD, 09/30/2002 -- 07/31/2006
2002
CORE--GENE EXPRESSION
Geraci, Mark W
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5P30CA046934-15), $250,404USD, 05/06/2002 -- 01/31/2003
 
CORE--GENE EXPRESSION
Geraci, Mark W
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 3P30CA046934-15S1), $250,404USD, 05/06/2002 -- 01/31/2003
 
Expression Analysis to Study Disease Pathogenesis
Geraci, Mark W
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 1R01HL072340-01), $744,067USD, 09/30/2002 -- 07/31/2006
 
Molecular Biology Core
Geraci, Mark W
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 1P01HL068743-01A1), $237,381USD, 07/01/2002 -- 06/30/2006
2001
CORE--GENE EXPRESSION
Geraci, Mark W
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 3P30CA046934-14S2), $250,404USD, 07/10/2001 -- 01/31/2002